CAMBRIDGE, MA, QurAlis Corporation, a clinical-stage biotechnology company, has closed an oversubscribed $88 million Series B financing, led by EQT Life Sciences.
QurAlis Closes $88 Million Series B
CAMBRIDGE, MA, QurAlis Corporation, a clinical-stage biotechnology company, has closed an oversubscribed $88 million Series B financing, led by EQT Life Sciences.
